Готові списки джерел за темами / COVID-19 (coronavirus disease 2019)

Добірка наукової літератури з теми "COVID-19 (coronavirus disease 2019)"

Автор: Grafiati
Опубліковано: 10 грудня 2022
Оновлено: 28 січня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "COVID-19 (coronavirus disease 2019)".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "COVID-19 (coronavirus disease 2019)"

1

Aysha Azhar. "CORONAVIRUS DISEASE 2019 (COVID-19)." Journal of University Medical & Dental College 11, no. 3 (September 25, 2020): v—vi. http://dx.doi.org/10.37723/jumdc.v11i3.487.

Повний текст джерела
Анотація:
The epidemic of 2019 novel coronavirus (2019-nCoV) has been emerged from a major city named Wuhan in the Hubei Province of China. It appears to have the potential to cause a major health problem globally. Earlier it is called 2019-nCoV but now this virus is taxonomically termed SARS-CoV-2. World Health Organization has named it as “coronavirus disease 2019” and abbreviated “COVID-19” [1].
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Goldust, Mohamad. "Coronavirus Disease 2019 (COVID-19)." Biology 11, no. 8 (August 22, 2022): 1250. http://dx.doi.org/10.3390/biology11081250.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Xiang, Kai Yan, Zi Yue Zu, Guang Ming Lu, and Long Jiang Zhang. "Coronavirus Disease 2019 (COVID-19)." Journal of Thoracic Imaging 35, no. 4 (May 1, 2020): 234–38. http://dx.doi.org/10.1097/rti.0000000000000528.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Aminul Hoque, AKM. "Coronavirus disease 2019 (COVID-19)." Anwer Khan Modern Medical College Journal 11, no. 2 (August 10, 2020): 89–90. http://dx.doi.org/10.3329/akmmcj.v11i2.62749.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Sadeghi Dousari, Amin, Majid Taati Moghadam, and Naghmeh Satarzadeh. "COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease." Infection and Drug Resistance Volume 13 (August 2020): 2819–28. http://dx.doi.org/10.2147/idr.s259279.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Seo, Jun-Won, Da-Young Kim, Nara Yun, and Dong-Min Kim. "Coronavirus Disease 2019-Associated Coagulopathy." Microorganisms 10, no. 8 (August 2, 2022): 1556. http://dx.doi.org/10.3390/microorganisms10081556.

Повний текст джерела
Анотація:
Coronavirus disease 2019 (COVID-19)-associated coagulopathy is an acute illness characterized by thrombosis with or without hemorrhage after COVID-19 infection. Clinical symptoms of COVID-19-associated coagulopathy can occur at any anatomical site. Various forms of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, are common in acutely ill patients with COVID-19. Laboratory findings, such as D-dimer and platelet counts, can help diagnose COVID-19-associated coagulopathy. Anticoagulation using direct oral anticoagulants and low-molecular-weight heparin is essential for the treatment of COVID-19-associated coagulopathy. Prophylactic anticoagulants are important in preventing COVID-19-associated coagulopathy in patients with severe COVID-19. In particular, the early initiation of prophylactic anticoagulation in patients with COVID-19 can improve survival rates without the risk of serious bleeding events.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Saini, Mahendra, Nikhita Parihar, Shankar Lal Soni, and Vandana Sharma. "Coronavirus Disease-2019 (COVID-19): An Overview." Asian Journal of Pharmaceutical Research and Development 9, no. 1 (February 15, 2021): 202–5. http://dx.doi.org/10.22270/ajprd.v9i1.896.

Повний текст джерела
Анотація:
There is a new public health crises threatening the world with the emergence and unfold of two019 novel coronavirus (2019-nCoV) or the severe acute metabolism syndrome coronavirus two (SARS-CoV-2). COVID-19 is a spread of coronavirus is the family Coronaviridae. The malady is believed to originate from crackers Associate in Nursing was unfold to people through unknown medium in an exceedingly town, China. Severe acute metabolism syndrome coronavirus 2 (SARS- CoV-2) could also be a very transmissible and infective coronavirus that emerged in late 2019 and has caused an outbreak|avirus|a virulent disease|a pestilence} of acute disease, named, ‘coronavirus malady 2019’ (COVID-19), that threatens human health and public safety. throughout this Review, we have a tendency to to tend to explain the essential medicine of SARS- CoV-2, together with genomic characteristics, and receptor use, lightness its key distinction from antecedent acquainted coronaviruses. we have a tendency to to tend to summarize current data of clinical, medicine, and pathological choices of COVID-19, additionally as recent progress in animal models, and antiviral treatment approach for SARS- CoV-2 infection. we have a tendency to to tend to to boot discuss the potential life hosts and disease origin of this rising virus well.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Gerloff, Christian, Peter Berlit, and Christine Klein. "COVID-19(„coronavirus disease 2019“)-Impfung." DGNeurologie 4, no. 2 (February 23, 2021): 75–77. http://dx.doi.org/10.1007/s42451-021-00309-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Hageman, Joseph R. "The Coronavirus Disease 2019 (COVID-19)." Pediatric Annals 49, no. 3 (March 1, 2020): e99-e100. http://dx.doi.org/10.3928/19382359-20200219-01.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Sorace, Paul, James R. Churilla, Thomas P. Mahady, and William O. Roberts. "Coronavirus Disease 2019 (COVID-19) Infection." ACSM'S Health & Fitness Journal 24, no. 6 (November 2020): 48–50. http://dx.doi.org/10.1249/fit.0000000000000617.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "COVID-19 (coronavirus disease 2019)"

1

Quevedo-Ramirez, Andres, Ali Al-kassab-Córdova, Carolina Mendez-Guerra, Gonzalo Cornejo-Venegas, and Kenedy P. Alva-Chavez. "Altitude and excess mortality during COVID-19 pandemic in Peru." Elsevier B.V, 2020. http://hdl.handle.net/10757/654524.

Повний текст джерела
Анотація:
We have read with interest the short communication published by Segovia-Juarez et al., 2020 in Respiratory Physiology & Neurobiology establishing that high altitude reduces the infection rate of COVID-19 but not the case fatality rate in the Peruvian setting. We support this hypothesis, however there could be an important number of under registered deaths on account of a low rate of diagnostic tests performed per inhabitant and mostly in symptomatic patients (Pasquariello and Stranges, 2020).
Revisión por pares
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Yáñez, Jaime A., Aldo Alvarez-Risco, and Jaime Delgado-Zegarra. "Covid-19 in Peru: From supervised walks for children to the first case of Kawasaki-like syndrome." BMJ Publishing Group, 2020. http://hdl.handle.net/10757/652436.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Alvarez-Risco, Aldo, Christian R. Mejia, Jaime Delgado-Zegarra, Shyla Del-Aguila-Arcentales, Arturo A. Arce-Esquivel, Mario J. Valladares-Garrido, Portal Mauricio Rosas Del, et al. "The Peru approach against the COVID-19 infodemic: Insights and strategies." American Society of Tropical Medicine and Hygiene, 2020. http://hdl.handle.net/10757/655502.

Повний текст джерела
Анотація:
The COVID-19 epidemic has spawned an "infodemic,"with excessive and unfounded information that hinders an appropriate public health response. This perspective describes a selection of COVID-19 fake news that originated in Peru and the government's response to this information. Unlike other countries, Peru was relatively successful in controlling the infodemic possibly because of the implementation of prison sentences for persons who created and shared fake news. We believe that similar actions by other countries in collaboration with social media companies may offer a solution to the infodemic problem.
Revisión por pares
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Cayo-Rojas, César F., and Ana Sofía Miranda-Dávila. "Empathy in medical education: An opportunity after the COVID-19 crisis." Universidad de Ciencias Medicas de La Hab, 2020. http://hdl.handle.net/10757/655703.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Yáñez, Jaime A., Asghar Afshar Jahanshahi, Aldo Alvarez-Risco, Jizhen Li, and Stephen X. Zhang. "Anxiety, distress, and turnover intention of healthcare workers in Peru by their distance to the epicenter during the COVID-19 crisis." American Society of Tropical Medicine and Hygiene, 2020. http://hdl.handle.net/10757/654523.

Повний текст джерела
Анотація:
We conducted a cross-sectional survey to assess the anxiety, distress, and turnover intention (likelihood to leave their current job) of healthcare workers in Peru during the COVID-19 pandemic. Our results reported that 21.7% healthcare workers in Peru experienced severe anxiety, whereas 26.1% of them experienced severe mental distress. A higher level of education related with a lower level of anxiety. Younger workers had a higher level of turnover intention than their older colleagues did. Healthcare workers in the private sector had a higher turnover intention than those in the public sector. Most importantly, people who were geographically far from Lima, the epicenter in Peru, during the outbreak experienced less anxiety and mental distress, corroborating the ripple effect and disconfirming the typhoon eye theory. However, the direction of these relationships can change depending on the type of institutions (public versus private) and the type of employees' contract (full time versus part time). Our research helps provide insights for clinical professionals in identifying the vulnerable groups to mental disorders in Peru. This is the first study to assess anxiety, mental distress, and turnover intention in healthcare workers in Peru during the COVID-19 pandemic. Copyright
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Benites-Flores, Irwing R., Renzo P. Valdivia-Vega, Susan F. Alcalde-Ruiz, and Hugo J. Espinoza-Rojas. "Clinical characteristics of acute kidney injury in the first 13 critically ill patients infected with SARS-CoV-2 (COVID-19) at a peruvian hospital; a preliminary report." Society of Diabetic Nephropathy Prevention, 2021. http://hdl.handle.net/10757/655813.

Повний текст джерела
Анотація:
Introduction: The high transmissibility and lethality of the novel coronavirus SARS-CoV-2 (COVID-19) have been catastrophic. Acute kidney injury (AKI) is one of the frequent complications in patients with respiratory insufficiency caused by the virus. The pathogenic mechanism is based on the binding of its S-proteins to the angiotensin-converting enzyme (ACE) receptors, which will trigger a cellular damage. A podocyte and tubular compromise are found in the kidneys which can lead to tubular necrosis and the consequent AKI. Objectives: The objective of this report is to identify the main risk factor to develop AKI in patients infected with SARS-CoV-2 with critical acute respiratory distress. Patients and Methods: We performed this report study, collecting data from 48 ICU patients. Data from 13 of them who developed AKI and needed renal replacement therapy (RRT)were analyzed. Clinical characteristics and laboratory findings were reported using STATA 10.0. Results: AKI was present in 27.08% of patients, mostly male (92.3%) with a mean age of 63.8 years old. Hypertension, diabetes and obesity were the main comorbidities in those patients. Additionally, the meantime between admission and AKI diagnosis was 2.69 days. All patients showed fibrinogen, D-dimer, ALT and values above normal range. Mortality was seen in 61.5% of patients. Conclusion: This report tries to show AKI as an important clinical manifestation in critically ill patients infected with SARS-CoV-2, with high mortality. Further studies are needed to demonstrate if there are independent risk factors.
Revisión por pares
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wang, Peiyu. "Strategy and molecular mechanism study of cold atmospheric plasma applications in oncotherapy, virucide and nanotechnology." Thesis, Queensland University of Technology, 2021. https://eprints.qut.edu.au/214016/1/Peiyu_Wang_Thesis.pdf.

Повний текст джерела
Анотація:
This thesis is the study of cold atmospheric plasma (CAP) applications in cancer, anti-viral treatments, and nano-biotechnology. The optimal treatment strategy, potential molecular mechanism and methods to increase selectivity and efficiency of plasma treatment were investigated for each application. In the near future, CAP or plasma activated medium (PAM) would likely become a widely used, high-efficiency and targeted clinical therapeutic tool.
Стилі APA, Harvard, Vancouver, ISO та ін.
8

ALTAMIRA, Asociación Peruana de Bibliotecas Académicas. "Boletín diario de información científica N° 19." Asociación Peruana de Bibliotecas Académicas ALTAMIRA, 2020. http://hdl.handle.net/10757/651877.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

ALTAMIRA, Asociación Peruana de Bibliotecas Académicas. "Boletín diario de información científica N° 33." Asociación Peruana de Bibliotecas Académicas ALTAMIRA, 2020. http://hdl.handle.net/10757/652002.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

ALTAMIRA, Asociación Peruana de Bibliotecas Académicas. "Boletín diario de información científica N° 35." Asociación Peruana de Bibliotecas Académicas ALTAMIRA, 2020. http://hdl.handle.net/10757/652005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "COVID-19 (coronavirus disease 2019)"

1

Saxena, Shailendra K., ed. Coronavirus Disease 2019 (COVID-19). Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4814-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Rezaei, Nima, ed. Coronavirus Disease - COVID-19. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63761-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Alshurideh, M. T., Aboul Ella Hassanien, and Ra’ed Masa’deh, eds. The Effect of Coronavirus Disease (COVID-19) on Business Intelligence. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-67151-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Barral-Netto, Manoel, Maurício L. Barreto, Elzo Pereira Pinto Junior, and Erika Aragão, eds. Construção de conhecimento no curso da pandemia de COVID-19: Aspectos biomédicos, clínico-assistenciais, epidemiológicos e sociais. Salvador, Brazil: EDUFBA, 2020.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Moretti, Anna, and Francesco Zirpoli. Osservatorio sulla componentistica automotive italiana 2020. Venice: Fondazione Università Ca’ Foscari, 2020. http://dx.doi.org/10.30687/978-88-6969-482-0.

Повний текст джерела
Анотація:
Nell’anno 2020 l’Italia ha dovuto fare i conti con la crisi sanitaria ed economica determinata dalla diffusione del virus COVID-19. La straordinarietà della situazione, con l’Europa alle prese con lockdown e fermi produttivi, ha portato l’Osservatorio a far seguire alla tradizionale rilevazione avviata a fine Febbraio 2020 una seconda indagine di approfondimento mirata a raccogliere le prime reazioni delle imprese della filiera alla crisi da coronavirus. Questa edizione del volume è, quindi, particolarmente ricca di spunti in quanto collega la fotografia del 2019 alla situazione generata dalla pandemia nel 2020. Il quadro complessivo è quello di una filiera i cui risultati in termini di fatturato, produzione ed export erano già in contrazione nel 2019 e, di conseguenza, particolarmente esposta alla crisi del 2020, soprattutto per alcune categorie di imprese meno resilienti. Il superamento di questa situazione critica potrà giocarsi sulla capacità di sviluppare aggregazioni e reti per l’innovazione, con obiettivi importanti di competitività dell’intera filiera sullo scenario internazionale.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Coronavirus disease 2019 (COVID-19) and family farming. FAO, 2020. http://dx.doi.org/10.4060/cb0417en.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Coronavirus disease 2019 (COVID-19) | Addressing the impacts of COVID-19 in food crises. FAO, 2020. http://dx.doi.org/10.4060/ca9192en.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Heinrich, Michael, Javier Echeverria, Adolfo Andrade-Cetto, Jon Wardle, Jia-bo Wang, and Hung-Rong Yen, eds. Ethnopharmacological Responses to the Coronavirus Disease 2019 (COVID-19) Pandemic. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-118-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Placencia López, Bárbara Miladys, Fernanda Vanessa Alcívar Macías, José Aníbal Sánchez Saltos, Mayra Alejandra Cedeño Mera, Silvia Beatriz Alarcón Barreiro, María Gabriela Pertuz Alarcón, Jacqueline Beatriz Delgado Molina, José Roberto Rodríguez Mera, Agustina Elizabeth Cedeño Casanova, and Christian Paúl Vera Zambrano. Covid 19. Mawil Publicaciones de Ecuador, 2022, 2022. http://dx.doi.org/10.26820/978-9942-602-37-4.

Повний текст джерела
Анотація:
El siglo XXI se ha caracterizado desde sus inicios por una problemática de salud que ha afectado al mundo, que va desde un incremento de la resistencia microbiana, aumento de las enfermedades oncológicas hasta la aparición de nuevas enfermedades infecciosas emergentes y reemergentes, como ha sido la aparición de la COVID-19 a finales del pasado año. Los coronavirus son una extensa familia de virus que pueden causar enfermedades tanto en animales como en humanos. En los humanos, se sabe que varios coronavirus causan infecciones respiratorias que pueden ir desde el resfriado común hasta enfermedades más graves como el síndrome respiratorio de Oriente Medio (MERS) y el síndrome respiratorio agudo severo (SRAS). La COVID-19 (coronavirus disease 2019) también conocida como enfermedad por nuevo coronavirus es causada por el coronavirus del síndrome respiratorio agudo severo (SARS-CoV-2), su forma es redonda u ovalada y a menudo polimórfica, tiene un diámetro de 60 a 140 nm, la proteína espiga que se encuentra en la superficie del virus y forma una estructura en forma de barra, es la estructura principal utilizada para la tipificación, la proteína de la nucleocápside encapsula el genoma viral y puede usarse como antígeno de diagnóstico. Produce síntomas similares a los de la gripe, entre los que se incluyen fiebre, tos, disnea, mialgia y fatiga. También se ha observado la pérdida súbita del olfato y el gusto (sin que la mucosidad fuese la causa). En casos graves se caracteriza por producir neumonía, síndrome de dificultad respiratoria aguda, sepsis y choque séptico que conduce a alrededor del 3 % de los infectados a la muerte, aunque la tasa de mortalidad se encuentra en 4,48 % y sigue ascendiendo.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

The Niger | Revised humanitarian response (May–December 2020): Coronavirus disease 2019 (COVID-19). FAO, 2020. http://dx.doi.org/10.4060/cb0180en.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "COVID-19 (coronavirus disease 2019)"

1

Wilson, Michael, and Philippa J. K. Wilson. "Coronavirus Disease 2019 (COVID-19)." In Close Encounters of the Microbial Kind, 185–96. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-56978-5_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Mesquita, Cláudio Tinoco, and Maria Fernanda Rezende. "Nuclear Cardiology and Coronavirus Disease 2019 (COVID-19) Pandemic." In Nuclear Cardiology, 247–63. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62195-7_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Makvandi, Somayeh, Mitra Mahdavian, Goli Kazemi-Nia, Amir Vahedian-Azimi, Paul C. Guest, Leila Karimi, and Amirhossein Sahebkar. "The 2019 Novel Coronavirus Disease in Pregnancy: A Systematic Review." In Clinical, Biological and Molecular Aspects of COVID-19, 299–307. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-59261-5_27.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Saxena, Shailendra K., Swatantra Kumar, Vimal K. Maurya, Raman Sharma, Himanshu R. Dandu, and Madan L. B. Bhatt. "Current Insight into the Novel Coronavirus Disease 2019 (COVID-19)." In Medical Virology: From Pathogenesis to Disease Control, 1–8. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4814-7_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Srivastava, Nishant, Preeti Baxi, R. K. Ratho, and Shailendra K. Saxena. "Global Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19)." In Medical Virology: From Pathogenesis to Disease Control, 9–21. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4814-7_2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Padhi, Abhishek, Swatantra Kumar, Ekta Gupta, and Shailendra K. Saxena. "Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection." In Medical Virology: From Pathogenesis to Disease Control, 95–107. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4814-7_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Dwivedi, Durgesh K., Anit Parihar, Neera Kohli, Himanshu R. Dandu, and Shailendra K. Saxena. "Radiological Perspective of the Novel Coronavirus Disease 2019 (COVID-19)." In Medical Virology: From Pathogenesis to Disease Control, 37–49. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-6006-4_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Malarvili, M. B., and Alexie Mushikiwabeza. "Assessment and Diagnostic Methods for Coronavirus Disease 2019 (COVID-19)." In Analysis of Medical Modalities for Improved Diagnosis in Modern Healthcare, 113–32. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9781003146810-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Lau, Harry Cheuk-Hay, and Jun Yu. "Gut Microbiota in Coronavirus Disease 2019." In Microbiome in Gastrointestinal Cancer, 289–302. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-19-4492-5_18.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Tanzini, Michela, Elisa Romano, Aldo Bonaventura, Alessandra Vecchié, and Micaela La Regina. "Coping with the COVID-19 Pandemic: Roles and Responsibilities for Preparedness." In Textbook of Patient Safety and Clinical Risk Management, 485–96. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-59403-9_34.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "COVID-19 (coronavirus disease 2019)"

1

Damayanti, Lina. "Cutaneous Manifestation of Coronavirus Disease 2019 (COVID-19)." In 12th Annual Scientific Meeting, Medical Faculty, Universitas Jenderal Achmad Yani, International Symposium on "Emergency Preparedness and Disaster Response during COVID 19 Pandemic" (ASMC 2021)). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/ahsr.k.210723.036.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Jiang, Chenkai. "A Molecular View of Coronavirus Disease-2019 (COVID-19)." In ICBBE '20: 2020 7th International Conference on Biomedical and Bioinformatics Engineering. New York, NY, USA: ACM, 2020. http://dx.doi.org/10.1145/3444884.3444908.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Huang, W., and T. Shu. "Thrombosis in the Patients with Coronavirus Disease 2019 (COVID-19)." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3841.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Rahi, M. S., K. Amoah, K. Gunasekaran, and M. Buscher. "Guillain-Barre Syndrome Related to Coronavirus Disease-2019 (COVID-19) Infection." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2472.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Aparece-Solis, S. S. O., R. Z. Perez, A. L. Y. Ong, M. T. A. Cañete, and A. L. Rafanan. "Tocilizumab Treatment in Severe to Critical Coronavirus Disease 2019 (COVID-19) Patients." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3840.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Katta, S., and M. R. Khoshnevis. "Fatal Invasive Pulmonary Aspergillosis Associated with Coronavirus Disease 2019 (COVID 19) Infection." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4081.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Skvortsov, A., A. Balakhonov, and A. Panferov. "Chitotriosidase Activity in Lung Injury Associated with Coronavirus Disease 2019 (COVID-19)." In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1288.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Frendiana, Viving, and Dandun Widhiantoro. "Design of Android Application System for Coronavirus Disease 2019 (COVID-19) Detection." In Annual Southeast Asian International Seminar. SCITEPRESS - Science and Technology Publications, 2020. http://dx.doi.org/10.5220/0010508300180022.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Mohammed, M. N., Nurul Aslamiah Hazairin, Arif Sameh Arif, S. Al-Zubaidi, Mohammed Hazim Alkawaz, A. K. Sairah, Ahmad Izzul Iman Md Jazlan, and Eddy Yusuf. "2019 Novel Coronavirus Disease (Covid-19): Toward a Novel Design for Disinfection Robot to Combat Coronavirus (Covid-19) Using IoT Based Technology." In 2021 IEEE 12th Control and System Graduate Research Colloquium (ICSGRC). IEEE, 2021. http://dx.doi.org/10.1109/icsgrc53186.2021.9515257.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Ahmad, M., S. Rehman, G. Aftab, and D. S. Frenia. "A Missed Opportunity or Collateral Damage of Coronavirus Disease of 2019 ( COVID-19)?" In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4860.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "COVID-19 (coronavirus disease 2019)"

1

Zhao, Junyu, Yutian Tian, Haipeng Wang, Jinming Yao, Wang Song, and Yaru Mou. Thyroid diseases are associated with coronavirus disease 2019 (COVID-19) infection. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0079.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Ding, Yukang, Xixia Chen, and Yongpeng Ge. Inflammatory myopathy following coronavirus disease 2019 vaccination: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0084.

Повний текст джерела
Анотація:
Review question / Objective: Reports of unexpected side effects have accompanied the vaccination of larger proportions of the population against coronavirus disease 2019 (COVID-19), including a few cases of inflammatory myopathy (IM). In a bid to improve understanding of the clinical course of vaccine complications, a systematic review of reported cases of IM following COVID-19 vaccination has been conducted. Condition being studied: Safety concerns have surrounded the vaccines since their development, with common adverse effects including local reaction at the site of injection and diverse non-specific flu-like symptoms (9). Most symptoms occur soon after vaccination and resolve within a short period but some serious events such as myopericarditis and cerebral venous thrombosis post COVID-19 vaccination had been reported. Meanwhile, some rare cases of vaccine-associated IMs have been reported. The current study systematically reviewed IM cases reported post-COVID-19 vaccination to date. Clinical and laboratory features are described and therapy and prognosis discussed.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Zhang, Xiaolin, Xue Yang, Hongmei Jiao, and Xinmin Liu. Coagulopathy in patients with Coronavirus Disease 2019（COVID-19）：a systemetic review and meta-analysis. International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0004.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Gupta, Tejpal, Sadhana Kannan, Babusha Kalra, and Prafulla Parikh. Coronavirus disease 2019 (COVID-19) and Medical/Pharmacological Therapies (CoMeT): A Network Meta-Analysis Protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0057.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Yang, Xue, and Xiaolin Zhang. Venous thromboembolism in patients with Coronavirus Disease 2019 (COVID-19): a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0024.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Qin, Hua, Yanu Prasetyo, Christine Sanders, Elizabeth Prentice, and Muh Syukron. Perceptions and behaviors in response to the novel coronavirus disease 2019 (COVID-19) : reports on major survey findings. University of Missouri, Division of Applied Social Sciences, 2020. http://dx.doi.org/10.32469/10355/79261.

Повний текст джерела
Анотація:
The United States has been affected by an extensive novel coronavirus (COVID-19) outbreak since March 2020. On March 9, 2020 we started an online survey of people’s perceptions and behaviors related to this issue in Missouri and adjacent states (Kansas, Iowa, Illinois, and Arkansas). The survey was ended on June 9, 2020 and in total 7,392 surveys were completed. In order to assess how attitudes and behaviors related to COVID-19 may change over time, two follow-up surveys were conducted with those respondents who indicated interest in the re-surveys and provided an email address. These two working reports summarize major results of the initial survey and three survey waves, including respondents’ perceived severity of the COVID-19 outbreak, sources of information, knowledge about COVID-19, perceptions of COVID-19 risk, satisfaction with management entities, and preventive actions.
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Li, Runmin, Ying Li, Bingchen Li, Haiyang Sun, Xinyu Liu, Xin Ge, Yuanxiang Liu, and Jiguo Yang. Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2020. http://dx.doi.org/10.37766/inplasy2020.7.0024.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Nguyen, Thin, Sunil Gupta, Jaishankar Raman, Rinaldo Bellomo, and Svetha Venkatesh. Geolocated Twitter-based population mobility in Victoria, Australia, during the staged COVID-19 restrictions. Critical Care and Resuscitation, December 2020. http://dx.doi.org/10.51893/2020.4.sc1.

Повний текст джерела
Анотація:
Using geotagged Twitter data in Victoria, we created a mobility index and studied the changes during the staged restrictions during the coronavirus disease 2019 (COVID-19) pandemic. We describe preliminary evidence that geotagged Twitter data may be used to provide real-time population mobility data and information on the impact of restrictions on such mobility.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Chhoeung, Norinmony, Sesokunthideth Chrea, and Nghia Nguyen. Cambodia’s Cash Transfer Program during COVID-19. Asian Development Bank Institute, December 2022. http://dx.doi.org/10.56506/rrmz8095.

Повний текст джерела
Анотація:
In 2019, Cambodia had been enjoying its steady economic growth until the coronavirus disease (COVID-19) pandemic hit the country from February 2020 in the form of severe infectious diseases, causing both economic and social problems for people from all walks of life, especially poor and vulnerable families. The IDPoor Equity Card, a poverty identification and registration system, was introduced in Cambodia to provide cash to poor pregnant women and children since 2016. Given its continued success, Cambodian Prime Minister Samdech Hun Sen announced the implementation of the Cash Transfer Program (CTP) using the IDPoor Card system. The CTP provided cash to poor and vulnerable households across the country affected by the pandemic. Executing the first large-scale cash transfer program in history presented significant challenges for the Government of Cambodia. In addition to implementing the program, which had to adhere to the three principles of equity–equality–efficiency, the government had other challenges to overcome, such as the limited number of tablets and facilities to accommodate the many people waiting in line to withdraw cash. Under the guidance of the central government, particularly the Economic and Finance Policy Committee, a technical working group was established to lead the implementation process; coordination among local governments, local councils, agencies, and the poor and needy; review of the IDPoor database; establishment of the digital payment system; and training of local government staff. This enabled the CTP to effectively distribute cash to poor and vulnerable households during the pandemic.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Thompson, Joseph. How WASH Programming has Adapted to the COVID-19 Pandemic. Institute of Development Studies (IDS), December 2020. http://dx.doi.org/10.19088/slh.2021.001.

Повний текст джерела
Анотація:
Since first appearing at the end of 2019, the novel coronavirus disease (COVID-19) has spread at a pace and scale not seen before. On 11 March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. A rapid response was called for, and actors across the globe worked quickly to develop sets of preventative measures to contain the disease. One mode of transmission identified early on in the crisis was via surfaces and objects (fomites) (Howard et al. 2020). To combat this, hand hygiene was put forward as a key preventative measure and heralded as ‘the first line of defence against the disease’ (World Bank 2020). What followed was an unprecedented global focus on handwashing with soap. Health messages on how germs spread, the critical times at which hands should be washed, and methods for correct handwashing were shared (Centers for Disease Control and Prevention 2020). Political leaders around the world promoted handwashing and urged people to adopt the practice to protect against the coronavirus. The primary and secondary impacts of COVID-19 have affected people and industries in a variety of different ways. For the WASH sector, the centring of handwashing in the pandemic response has led to a sudden spike in hygiene activity. This SLH Rapid Topic Review takes stock of some of the cross-cutting challenges the sector has been facing during this period and explores the adaptations that have been made in response. It then looks forwards, thinking through what lies ahead for the sector, and considers the learning priorities for the next steps.
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "COVID-19 (coronavirus disease 2019)" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії